61
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Improving the global management of the neurogenic bladder patient: part I. The complexity of patients

, , , , , , , & show all
Pages 359-365 | Accepted 15 Dec 2005, Published online: 13 Jan 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pierre Denys, Jacques Corcos, Karel Everaert, Emmanuel Chartier-Kastler, Clare Fowler, Vinay Kalsi, Victor Nitti, Heinrich Schulte-Baukloh & Brigitte Schurch. (2006) Improving the global management of the neurogenic bladder patient: part II.Future treatment strategies. Current Medical Research and Opinion 22:5, pages 851-860.
Read now

Articles from other publishers (6)

C Hui, X Keji, J Chonghe, T Ping, O Rubiao, Z Jianweng, D Xiangrong, Z Liling, H Maping, L Qingqing, L Qiuling, H Jiebing & H Tanghai. (2015) Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity. Spinal Cord 54:1, pages 46-50.
Crossref
Y. Santiago-Lastra & J. T. Stoffel. (2015) Literature Review: Long-Term Complications of the Neurogenic Bladder. Current Bladder Dysfunction Reports 10:4, pages 338-345.
Crossref
A. Wagg, L. Cardozo, C. Chapple, D. C. Diaz, D. De Ridder, M. Espuna-Pons, F. Haab, C. Kelleher, H. Kolbl, I. Milsom, P. Van Kerrebroeck, M. Vierhout & M. Kirby. (2008) Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?. International Journal of Clinical Practice 62:10, pages 1588-1593.
Crossref
Uta Kliesch & Armin Curt. 2008. Spinal Disorders. Spinal Disorders 291 318 .
Brigitte Schurch, Pierre Denys, Chris M. Kozma, Pat Ray Reese, Terra Slaton & Richard L. Barron. (2007) Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence. European Urology 52:3, pages 850-859.
Crossref
Pierre Denys, Alexis Schnitzler & Nicholas Roche. (2006) Managing Patients with Neurogenic Detrusor Overactivity—A Global Approach. European Urology Supplements 5:11, pages 691-695.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.